Proactive Post-Injection Monitoring in Brolucizumab Therapy: A Study on Intraocular Inflammation and Treatment Outcomes
This study highlights the incidence of IOI with Brolucizumab in a real-world setting, emphasizing the importance of proactive monitoring and early intervention. Despite the occurrence of inflammation, visual outcomes were generally favorable, supporting the safety of Brolucizumab when managed carefully.
Authors
- A. Balakrishnan (ORCID: https://orcid.org/0000-0001-8077-0133)
- Unnikrishnan Nair (ORCID: https://orcid.org/0000-0003-0894-5124)
- Jay Sheth (ORCID: https://orcid.org/0000-0002-3590-7759)
- Apoorva Jadhav (ORCID: https://orcid.org/0000-0002-3627-3268)
- Manoj Soman
Institutions
- Aditya Jyot Eye Hospital (IN)
- Chaithanya Eye Hospital and Research Institute (IN)
Publication Details
- Journal
- Clinical ophthalmology
- Published
- 2025-04-01
- DOI
- https://doi.org/10.2147/opth.s520118
- Citations
- 1
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.71